Back to Trades
Total Value
$12.5M
Filing Date
Feb 20, 2026
1 transactions
Trade Summary
On Feb 18, 2026, Demopulos Gregory A MD, Chairman, CEO & President, Director, reported $12.5M of OMEROS CORP (OMER) across 1 transactions. The filing covers Common stock and reflects balanced net activity of $0. Reported prices ranged from $10.27 to $11.93. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- OMEROS CORP
- Ticker Symbol
- OMER
- CIK
- 0001285819
Insider Information
- Role
- Chairman, CEO & President, Director
- Location
- SEATTLE, WA
Filing Details
- Filing Date
- Feb 20, 2026
- Transaction Date
- Feb 18, 2026
- Accession Number
- 0001437749-26-004950
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Common stock | 400,000 | $10.27 | Exercise | $4.1M |
| Feb 18, 2026 | Common stock | 357,678 | $11.93 | Tax Withholding | $4.3M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | OMER derivative | 400,000 | $10.27 | Exercise | $4.1M |
Want live alerts when Demopulos Gregory A MD trades again?
Download Insider Trades to track OMER, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares withheld by Omeros Corporation ("Omeros") in connection with net share settlement to satisfy the exercise price and tax liability associated with the reporting person's exercise of stock options. The number of shares withheld was determined based on the closing price of Omeros' common stock on February 17, 2026. The transaction did not involve any open-market sale of securities, and all 357,678 withheld shares remained in the Omeros treasury.
- (F2)The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
- (F3)Shares held in the [Demopulos Child #1] Gift Trust, an irrevocable trust established for the benefit of a minor child of the reporting person.
- (F4)Shares held in the [Demopulos Child #2] Gift Trust, an irrevocable trust established for the benefit of a minor child of the reporting person.
- (F5)This option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2015.